Catalyst Pharmaceutical
CPRX
CPRX
142 hedge funds and large institutions have $202M invested in Catalyst Pharmaceutical in 2020 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 42 increasing their positions, 47 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
11% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 47
33% less capital invested
Capital invested by funds: $299M → $202M (-$97.2M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
142
Holding in Top 10
–
Calls
$827K
Puts
$297K
Top Buyers
| 1 | +$11.3M | |
| 2 | +$4.23M | |
| 3 | +$3.05M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.84M |
| 5 |
RA
Royce & Associates
New York
|
+$1.41M |
Top Sellers
| 1 | -$5.34M | |
| 2 | -$4.62M | |
| 3 | -$3.65M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.38M |
| 5 |
Two Sigma Investments
New York
|
-$1.97M |